Early Look

Tuesday, November 17, 2026

Futures

Up/Down

%

Last

Dow

-158.00

0.31%

51,510

S&P 500

7.25

0.10%

7,445

Nasdaq

135.50

0.50%

27,418

 

 

U.S. stock futures were down overnight, but have been perking up this morning as S&P futures and the Nasdaq turn positive, getting a boost after stocks tumbled on Monday. US stocks opened down yesterday and other than a couple weak rally attempts, slid all day, with the Nasdaq leading lower falling -2.5% as chip stocks sank (SOX -5.3%). The S&P 500 declined -1.9%, its worst day since Nov. 5th while the Russell 2000 dropped -1.8%. The focus today is on Nvidia's (NVDA) earnings report after the bell in what will likely be one of the biggest events of the week — eclipsed only by Anthropic's (ANT) IPO on Thursday. Nvidia's former CFO and now interim CEO Colette Kress will run the earnings call after Jensen Huang's abrupt resignation as CEO last week amid affair allegations. In Asian markets, The Nikkei Index declined -801 points to 58,860, the Shanghai Index dropped -18 points to 3,584, and the Hang Seng Index fell -245 points to 23,508. In Europe, the German DAX is down -193 points to 26,405, while the FTSE 100 slides -80 points to 10,800. Earnings out this morning for Disney (DIS) and Home Depot (HD) with recaps below. Optical stocks rise (AAOI, LITE, COHR, CIEN) after the U.S. moves ahead with Chinese data center Equipment restrictions despite big tech opposition

 

So what has been happening in the AI space of late? The AI trade has been breaking down with NVDA shares down 36% from its high (-13% last week alone ahead of earnings tonight), but is broadly impacting the entire AI chain.  Among semiconductor chips names off their respective 52-week highs you have NVDA -36%, MU -42%, AVGO -33%, TSM -23% and the SMH -31%, and −14% in a month. Meanwhile the AI infrastructure names are getting hit hardest on fears of slowing spending or partnerships as NBIS -64% off 52-week highs (−57% in 3 months), CRWV -64%, SMCI -51%, VRT -50% and ORCL -53%. The more leveraged a company is to AI spending, the worse it’s doing. Lastly, even the hyperscaler companies have been falling too as GOOGL -17% in a month, META -12% in a month and MSFT only down -7% from highs. The money has been rotating out of tech and into defensive sectors with Consumer Staples (XLP) and Healthcare (XLV) recently hitting all-time highs while Utilities (XLU) also stronger. The average stock is fine, though the crowded trade isn’t as money has been rotating out of AI and into defensives.

 

Lots of strange goings on the last few days that has many scratching their heads:

1) MSFT outage last Thursday into the weekend. Today, Microsoft said a software bug undetected since July triggered last week's worldwide disruption affecting Outlook, Teams, Copilot and other services. The failure began on November 11, when routine traffic rerouting overloaded servers and caused cascading system failures. At the outage's peak, more than 80% of Outlook servers were unresponsive. Microsoft took approximately 30 hours to identify the broader problem and begin deploying a fix.

2) On Friday, the FAA’s ancient router network (still running on copper in places, apparently) flooded itself during a routine upgrade and grounded the entire country for hours—the longest stop since 9/11.

3) Yesterday, Chase, Bank of America, Wells Fargo and others start having “technical bugs” that aren’t cyber-related. "Due to a technical issue, some transactions are taking longer than usual to complete but customers still have access to their accounts and funds. We are working to resolve this as quickly as possible," a spokesperson for Chase said. CNBC reported, citing a source, that there was no indication bad actors were involved in JPMorgan's technical issue and no sign that a bug was affecting multiple banks at the same time.

 

Market Closing Prices Yesterday

  • The S&P 500 Index dropped -145.08 points, or 1.92%, to 7,416.59
  • The Dow Jones Industrial Average fell -739.38 points, or 1.41%, to 51,608.17
  • The Nasdaq Composite tumbled -626.52 points, or 2.49%, to 24,509.76
  • The Russell 2000 Index declined -47.51 points, or 1.70% to 2,742.98

Economic Calendar for Today

  • 7:45 AM ET ICSC Weekly Retail Sales
  • 8:30 AM ET                   Retail Sales M/M for October…est. +0.2% (prior +0.8%)
  • 8:30 AM ET                   Retail Sales – Less Autos M/M for October…est. +0.4% (prior +0.9%)
  • 8:30 AM ET                   Import Prices M/M for October…est. +0.7% (prior +1.1%)
  • 8:30 AM ET                   Export Prices M/M for October…est. +0.5% (prior +2.2%)
  • 8:55 AM ET                   Johnson/Redbook Weekly Sales
  • 9:15 AM ET                   Industrial Production M/M for October…est. +0.1% (prior +0.7%)
  • 9:15 AM ET                   Capacity Utilization for October…est. 76.8% (prior 76.9%)
  • 10:00 AM ET                 Business Inventory M/M for September…est. +0.5% (prior +0.4%)
  • 10:00 AM ET NAHB Housing Market Index for November…est. 29 (prior 29)
  • 4:30 PM ET API Weekly Inventory Data

Earnings Calendar:

  • Earnings Before the Open: AS DIS ENR ESLT FUBO GFF HD HUYA JD KLAR LUXE MNSO ONEW OPRA SMWB SR TME VIK WB
  • Earnings After the Close: DLB GBDC GLAD IIIV IRIX LZB NVDA SQM WAST ZTO

Other Key Events:

  • Citizens Financial Services Conference, 11/17, in New York
  • Deutsche Bank Residential REIT summit (virtual), 11/17
  • Deutsche Bank 5th Annual Global Space Summit, 11/17-11/18, in New York
  • Jefferies 5th Miami Consumer Conference, 11/17-11/18, in Miami, FL
  • Piper Sandler Financial Services Conference, 11/16-11/18, in Miami, FL
  • RBC Capital Markets Global Industrials Conference 11/16-11/17, in New York
  • RBC Capital 2026 Global TIMT Conference, 11/17-11/18, in New York
  • Rosenblatt Silicon Valley field trip, 11/17-11/18
  • Roth Capital 13th Annual Solar & Storage Symposium at RE +, 11/16-11/18, Las Vegas
  • Roth Capital 15th Annual Technology Conference, 11/17-11/18, in New York
  • Supercomputing 2026, 11/15-11/20, in New Orleans
  • TD Cowen 2026 Financials & Fintech Conference, 11/17-11/18, in New York

 

 

Macro

Up/Down

Last

Nymex

0.32

86.04

Brent

0.41

92.85

Gold

4.40

3,857.40

EUR/USD

-0.0004

1.0994

JPY/USD

-0.20

159.18

10-Year Note

-0.03

5.12%

 

World News

  • New US intelligence indicates that Iran is developing plans to target senior Trump administration officials by detonating a so-called dirty bomb or a chemical weapon in Washington, DC, even as officials continue to debate whether Iran can or will attempt to execute such a plot, according to seven US officials – CNN
  • According to 13F filings: Global fund managers slashed their allocation to tech stocks by the most in a single month since June 2006, Bank of America's November Fund Manager Survey shows. 52% expect an AI hyperscaler to announce a cut to capital spending in the next six months, and a record 38% say companies are overinvesting.
  • RBA Minutes last night showed that inflation is expected to remain too high for another year, with risks still skewed to upside; members backing a hike judged previous 2026 increases insufficient to address inflation risks;  members against a hike feared economy could be near a sharper downturn; excess demand expected to persist until mid-2027.
  • Chinese retail sales rose 0.4% last month from a year ago, slowing from 1.1% in September, according to government data released Monday.

Sector News Breakdown

Consumer

  • Home Depot (HD) Q3 adj EPS $3.86 vs. consensus $3.84 and revs rose to $43.4B vs. consensus $42.78B; Q3 comparable sales up 2.2%; narrows FY26 EPS view to up 2% from flat to up 4% from $14.69 (est. $15.01) while narrows FY26 revenue view to up 4.5% from up 2.5%-4.5%; narrows FY26 comparable sales view to up 1.4% from flat to up 2%; maintains FY26 capital expenditures view 2.5% of total sales; named Richard McPhail as its next chief executive, elevating the retailer's finance chief to the position he has held on an interim basis since August, when Ted Decker took a temporary medical leave of absence.
  • Amer Sports (AS) Q3 adj EPS $0.42 vs. est. $0.35; Q3 revs rose 24% y/y to $2.17B vs. est. $2.14B; said all segments, geographies, and channels achieved double-digit growth led by another exceptional quarter from Salomon Softgoods, a strong Arc'teryx omni-comp, and continued solid Wilson Tennis; Q1 gross margins +250 bps y/y to 59.3%; raises FY26 EPS view to $1.32-$1.35 from $1.27-$1.30 and boosts FY26 revenue growth to 25%-26% from 24%; announces $1B share buyback plan.
  • GoPro Inc. (GPRO) Q3 Adjusted EPS ($0.24) vs. est. ($0.14) (miss); revenue $96.201Mm, down 41% Y/Y, with hardware down 49.5% and subscription/services up 3.1% to $27.434Mm; adjusted EBITDA loss $40.770Mm vs. $7.903Mm Y/Y; adjusted gross margin 12.8%, down 2,240bps Y/Y; cash $33.5Mm; no financial guidance or earnings call due to pending Starman Optical merger, with closing deadline extended to March 31, 2027.
  • Neighborhood Intelligence, Inc. (NXH) announces $25 million share repurchase program.

Energy, Industrials and Materials

  • AECOM (ACM) Q4 Adjusted EPS $1.63 vs. est. $1.58 (beat); revenue $3.878B vs. est. $1.925B (beat); adjusted EBITDA $358Mm vs. est. $350.7Mm (beat); adjusted operating Income $325Mm vs. est. $313.3Mm (beat); sees FY27 adjusted EPS $6.15-$6.35 vs est $6.00 (above) and adjusted EBITDA $1.35B-$1.39B vs est $1.343B (above).
  • Powell Industries (POWL) Q4 EPS $2.23 tops consensus $1.56 and revs rose 33% y/y to $396.71M vs. est. $335.1M; Q4 gross margins 34.9; Q4 New orders totaled $710M, an increase of 162%, representing a Q4 book-to-bill ratio(3) of 1.8x; backlog as of September 30, 2026, totaled $2.7 billion, an increase of 96%.
  • Red Cat Holdings (RCAT) Q3 EPS ($0.26) vs. est. ($0.19) (miss); revenue $11.8Mm vs. est. $39.5Mm (miss), up 22% Y/Y; operating loss $43.4Mm, operating expenses $43.5Mm; proposed Steyr Motors acquisition; withdraws previously announced full-year 2026 revenue target.
  • Consolidated Edison (ED) announces public offering of 6,000,000 common shares.

Financials

  • Berkshire Hathaway disclosed in an SEC filing its holdings as of September 30, 2026. Berkshire's one new buy during the third quarter was Bending Spoons (BSP). Berkshire increased its stake in a number of holdings, including by size of previous position, Lennar (LEN), Delta Air Lines (DAL), and Macy's (M). Berkshire reduced its stake in a number of holdings, including by size of previous position, Bank of America (BAC), DaVita (DVA), VeriSign (VRSN), Capital One (COF), and Kroger (KR).
  • Deutsche Bank (DB) shares fell after media reports based on leaked internal records renewed scrutiny of the German lender's past dealings with clients. Responding to the reports, Deutsche Bank said the matters described "date back many years", and that the bank had since strengthened its controls. In one incident, Deutsche Bank was reported by the Financial Times to have inadvertently sent a Trump tax document to another client's accountant in 2017 when the president was a Deutsche Bank client during his first term in office. The leaks also showed that Deutsche Bank was ambitious in pursuing business in Russia.
  • PagSeguro Digital (PAGS) Q3 recurring net Income R$611Mm, up 7% Y/Y from R$571Mm; reported net Income R$584Mm vs. est. R$585Mm (in line); total revenue and Income R$5.1B vs. est. R$5.2B (miss); declares cash dividend $0.26/share; sees further distribution of approximately R$400Mm in December 2026 and at least R$2B in distributions until 2028.
  • XP Inc. (XP) Q3 Gross revenue R$5.34B vs. est. R$5.1B (beat), up 8% Y/Y; adjusted EBT R$1.58B; client assets R$2.2T, net inflows R$22B; approves $0.46/Class A share dividend and up to R$1.5B buyback through Nov. 18, 2027.

Healthcare

  • Cardlytics (CDLX) announces plan to reduce workforce by 15% or 30 employees; expects operating expenses to decrease by $12.20M annually; estimates non-recurring charges of $0.70M for workforce reduction.
  • Enanta Pharmaceuticals (ENTA) Q4 EPS ($0.81) vs est ($0.78) (miss); revenue $12.868Mm vs. est. $14.6Mm (miss); operating loss $22.039Mm, operating expenses $34.907Mm; CEO Jay Luly to retire by February 2027.
  • Omeros Corp. (OMER) Q3 Adjusted EPS $0.06 vs. est. $0.02 (beat).
  • Praxis Precision (PRAX) upgraded to Overweight from Equal Weight at Wells Fargo and raised tgt to $509 from $343, more positive on the robustness of ulixacaltamide's D56 result.

Technology, Media & Telecom

  • Amazon (AMZN) said it plans to invest $7 billion in renewable energy in India by 2030. It also announced four new wind and solar projects in the country, including its largest wind farm contracted in Asia to date.
  • Disney (DIS) Q4 adj EPS $1.77 vs. est. $1.67 and revs rose 16% y/y to $25.95B vs. est. $25.18B and forecast continued growth in the new fiscal year; said it expects double-digit growth in adj EPS in FY27, ex: the impact of the extra week, adding that it expects the majority of the growth to occur in the first half of the year; said it would boost cash content spending to $26B next year, including by investing more in international programming and sports rights; raises dividend by 335% and targets $9B in FY27 buybacks.
  • Nvidia (NVDA) said it has established a new board-level committee to oversee its national security policies, export control ‌compliance and global trade risk management. The move comes days after the ‌resignation of CEO Jensen Huang amid revelations of his affairs, including with a suspected Chinese spy, ​raised questions about potential national security risks and the oversight of the AI chip designer's chip exports.
  • US Commerce Dept said they initiated an investigation into Megaspeed in 2024 for potential export control violations; in May 2025 investigators requested records from NVidia concerning direct or indirect sales to Megaspeed; in Jun 2025, NVidia placed Megaspeed on its no sell list.
  • Optical sector (AAOI, CIEN, GLW, COHR, LITE) rise as the U.S. Moves ahead with Chinese data center equipment restrictions despite big tech opposition. The FCC is seeking to block imports of new Chinese optical transceiver models over national security concerns, Reuters reports. Amazon, Google, Meta, Microsoft, CoreWeave and Cisco warned the White House that compliance could take up to 10 years.
  • Hedge fund Situational Awareness, run by former OpenAI executive Leopold Aschenbrenner, sharply cut stakes in AI and data center-related companies in Q3, filing shows. The Fund dissolves stake in neocloud firm CRWV, holds only "call" options in rival NBIS; fully exits positions in APLD, CORZ, RIOT and KEEL; cuts stake in data center operator IREN by 94.4%; holds only "call" options for SNDK vs over 2.49M shares in Q2; exits AI names MU, CBRS and HIVE completely.
  • Infleqtion Corp. (INFQ) Q3 EPS loss (-$0.09) vs. est. loss (-$0.05); Q3 revs rose 25% y/y to $9.1M vs. est. $11.03M; backs FY26 revenue view roughly $43M, vs. consensus $45.12M; Quarter-end cash, cash equivalents and available-for-sale securities totaled $560 million, with no debt.
  • JD.com (JD) Q3 adj profit 8.03 billion yuan ($1.20 billion) vs. 5.8 billion yuan y/y, while revs rose 3.5% from a year ago to 309.59 billion yuan (vs ests for adj profit of 7.96 billion yuan on revenue of 307.96 billion yuan).
  • Nokia (NOK) shares fell after Nvidia (NVDA) disclosed it cut its stake in the Finnish telecom-equipment maker by 56% in the third quarter.
  • ReposiTrak, Inc. (TRAK) Q1 EPS $0.08 vs. est. $0.08 (in line); revenue $5.784Mm vs. est. $5Mm (beat); operating Income $1.7Mm, operating expenses $4.1Mm; sees sequential revenue improvement through FY27 and another year of growth; notes a 49.99% Spar Group ownership position supporting its Touchless Retail strategy, with customer engagements exceeding 20

Mid-Morning Look

Tuesday, November 17, 2026

Index

Up/Down

%

Last

DJ Industrials

-439.33

0.85%

51,168

S&P 500

-49.66

0.67%

7,366

Nasdaq

-192.43

0.79%

24,317

Russell 2000

-17.01

0.62%

2,725

 

 

U.S. stocks have round-tripped since the open, with the Dow, S&P 500 and Nasdaq all reversing from its overnight futures gain to trade down as investor sentiment remains cautious ahead of NVDA earnings tonight and the Anthropic IPO mid-week. Investors cut their overweight to tech stocks by the most since 2006 in the latest Bank of America Global Fund Manager Survey. Bank of America's November fund manager survey shows a sharp increase in expectations for an Ai spending slowdown; 52% expect a major Ai hyperscaler to announce a capital expenditure cut within six months, up from 30% in October, while 40% do not anticipate such a reduction. The shift highlights growing investor concerns about the sustainability of Ai infrastructure spending and potential pressure on technology stocks. A very busy morning of economic data as well, including mush weaker housing data and industrial production, while both export and import top consensus and retail sales were in-line with economist expectations. Energy (XLE) and Materials (XLB) early leaders while tech (XLK) again leads to the downside.

 

President Trump landed in Manila, kicking off his Asian tour with a Quad summit focused on economic security and countering Beijing's influence before talks with Xi; Trump, Xi and Putin are due to meet at the APEC summit. President Trump also dismissed concerns over recent disruptions affecting Microsoft, JPMorgan Chase and U.S. Aviation systems. The incidents included a global Microsoft outage, an FAA Equipment failure that grounded flights for more than four hours, and Banking transaction delays. Speaking in Manila, Trump said the disruptions were under control and Assured Americans that travel remains safe ahead of Thanksgiving. The Euro falls to 19-month lows of $1.0982 as the dollar extends gains, while Treasury yields hold steady after a rip the last few days.

 

Ahead of NVDA earnings tonight, several items in the news again today: 1) NVDA warns customers of potential legal exposure under new offshore chip-access restrictions; will halt sales to data centers renting over 50% of their GPUs to Chinese firms, per CNBC; the company said it establishes a standing board committee overseeing national security, export compliance and global trade risk, alongside enhancements to internal compliance teams; 3) late yesterday the NVDA board said it is not considering reinstating Jensen Huang as CEO. This week also brings more AI headlines including the Anthropic IPO (Bloomberg reports likely to price IPO above current range of $70-$78) and also says has drawn multiple orders of $10B or more, and also November options expiry on Friday.

Economic Data

  • Oct retail sales rose +0.2%, in line with consensus +0.2%, while U.S. Oct Retail Sales Ex-autos +0.6% (above the consensus +0.4%) but below the September +1.1%; Excluding gas and autos, retail sales grew 0.5% M/M vs. +0.3% consensus and +0.5% prior (revised from +0.2%). miscellaneous store retailers posted the biggest increase, rising 4.7%, more than offsetting a 3.0% M/M decrease in September.
  • U.S. export prices rose 1.1% M/M in October vs. +0.3% consensus and +2.4% prior (revised from +2.2%); Import prices increased 1.1% M/M vs. +0.7% consensus and +1.1% in September. Higher prices for nonfuel imports drove the rise in October. U.S. Oct Petroleum import prices +3.7% vs Sept +6.2%.
  • Oct Industrial output declined -0.4% (vs. consensus +0.1%) and below the Sept +0.7%; Oct mining output fell -0.8% (vs. Sept -0.2%), Utilities output -4.3% (Sept +4.4%). Capacity Utilization use rate 76.4% (below consensus 76.8%) vs Sept 76.8% (previous 76.9%). Oct industrial output ex cars/parts -0.7% vs Sept +0.9%.
  • U.S. Sept Business Inventories +0.5%, in-line with consensus +0.5% and vs Aug +0.4%; Sept inventory/sales ratio 1.33 months' worth vs Aug 1.35 months; U.S. Sept business sales +1.8% vs Aug +1.2% (prev +1.1%). U.S. Sept retail inventories ex-autos revised to +0.5% (prev +0.4%).
  • U.S. November NAHB Housing market index 25, lowest level since 2012 and vs. consensus 29 and 29 in October (previous 29); November index of current single-family home sales 28 versus revised 34 in October (previous 33); November index of home sales over next six months 30 versus 32 in October (previous 32).

 

 

Macro

Up/Down

Last

WTI Crude

0.79

86.51

Brent

0.75

93.19

Gold

16.30

3,869.30

EUR/USD

0.0004

1.100

JPY/USD

-0.101

159.29

10-Year Note

0.018

5.14%

 

Sector Movers Today

  • Managed Care sector (ELV, CI, UNH, HUM) stocks under pressure after the Trump administration announced plans for a widespread crackdown targeting fraud and Waste across federal and State-sponsored health programs, including Medicare, Medicaid, and the Health Insurance Marketplace. The proposed rule titled the Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) is expected to save U.S. taxpayers nearly $90B over the next 10 years, the Centers for Medicare & Medicaid Services said in a statement. CRUSH would increase fraud reporting requirements for Medicare Advantage firms and Part D plan sponsors.
  • Optical sector (AAOI, CIEN, GLW, COHR, LITE) rise as the U.S. moves ahead with Chinese data center equipment restrictions despite big tech opposition. The FCC is seeking to block imports of new Chinese optical transceiver models over national security concerns, Reuters reports. Amazon, Google, Meta, Microsoft, CoreWeave and Cisco warned the White House that compliance could take up to 10 years.
  • Software sector broadly lower with aggressive pullbacks in shares of CRM, DDOG, FIG, MNDY, MDB, NOW, OKTA, TEAM , WDAY and many others – some speculating further source of funds selling ahead of the Anthropic IPO coming this week. Also Cleveland Research had cautious comments on both CRM and WDAY saying for CRM, said Q3 appeared in line but feedback softer vs prior (and JPM said Third-Party Surveys Point to Ai adoption hitting real-world challenges, even though disruption risk is limited), while for WDAY, says Q3 finished below partner plan.

 

Stock GAINERS

  • ACM +10%; after posts Q4 revenue and adj. EPS of $3.88B and $1.63, respectively, beating analysts' ests of $1.93B and $1.58 on record backlog growth of 13%; results were driven by record project wins, backlog growth, strong margins and robust demand for advisory services; guides year EPS $6.15-$6.35 vs. est. $6.19
  • AS +8%; shares rise on earnings beat after Q3 adj EPS $0.42 vs. est. $0.35; Q3 revs rose 24% y/y to $2.17B vs. est. $2.14B; said all segments, geographies, and channels achieved double-digit growth; raises FY26 EPS view to $1.32-$1.35 from $1.27-$1.30 and boosts FY26 revenue growth to 25%-26%.
  • COHR +3%; along with gains in other optical stocks AAOI after the U.S. moves ahead with Chinese data center equipment restrictions despite big tech opposition.
  • DIS +2%; posted a top and bottom line beat with Q4 adj EPS $1.77 vs. est. $1.67 and revs rose 16% y/y to $25.95B vs. est. $25.18B and said it expects double-digit growth in adj EPS in FY27, ex: the impact of the extra week, adding that it expects the majority of the growth to occur in the first half of the year; said it would boost cash content spending to $26B next year; raises dividend by 33% and targets $9B in buybacks.
  • NKE +3%; holding its first Investor Day in roughly a decade today, outlined its FY31 financial framework, with the outlook pointing to adjusted EPS of $3 to $3.50 on a 12%-14% operating margin, above Stifel expectations for an 11% EBIT margin and $3 EPS despite lower revenue.
  • SITE +5%; will replace ITGR in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, November 19
  • SLS +163%; as announced positive pivotal phase 3 regal trial data showing immunotherapeutic cancer vaccine, galinpepimut-s (GPS), demonstrated a statistically significant and clinically meaningful improvement in overall survival in patients with acute myeloid leukemia.

 

Stock LAGGARDS

  • CRM -7%; amid an aggressive selloff in software space this morning (HUBS, TEAM, WDAY, MDB).
  • DB -3%; after a series of media reports based on leaked documents detailed the lender's internal deliberations and handling of more than a decade's worth of missteps and scandals. A media consortium reported on failings in the bank's handling of high-risk customers.
  • OMER -18%; shares fell after Q3 revs $36M missed the $37.3M consensus while adj EPS $0.06 above est. $0.02; said growth in sales of Yartemlea, OMER's drug for treating stem cell transplant-related blood vessel damage, was partly offset by increased participation in 340B program.
  • PEP -2%; was downgraded to Underperform at Bernstein and trimmed tgt to $128 from $131 citing persistent weakness in North America, where it expects both the snacks and beverages businesses to continue losing volume and market share.
  • RCAT -31%; as Q3 earnings results materially missed expectations because of funding delays and the Gauntlet II outcome, prompting withdrawal of full-year guidance; reported Q3 EPS loss (-$0.26) vs. est. (-$0.19) and revenue $11.8Mm vs. est. $39.5Mm, up 22% Y/Y; operating loss $43.4Mm.
  • UNH -3%; along with weakness in HUM, CNC, ELV in managed care after the Trump administration announced plans for a widespread crackdown targeting fraud and Waste across federal and State-sponsored health programs.
  • VIK -1%; Q3 EPS and revs both fell short of consensus at $1.11 adj EPS vs. estimate $1.27 and revs rose 9% y/y to $2.18B but just below est. $2.2B; noted Q3 net income fell y/y to $498.37M; Advance bookings for the 2027 season climbed 17% versus the prior season’s comparable point

Closing Recap

Monday, November 16, 2026

Index

Up/Down

%

Last

DJ Industrials

-737.24

1.41%

51,610

S&P 500

-144.55

1.91%

7,417

Nasdaq

-626.52

2.49%

24,509

Russell 2000

-47.51

1.70%

2,742

 

 

 

 

 

 

 

 

 

U.S. stocks were better for sale most of Monday, with the S&P 500 and Nasdaq falling a third straight day as another concentrated AI themed/semiconductor selloff pulled the Nasdaq below the broader market (and further back below its key 200dma technical support). Investors now await NVDA earnings Tuesday night and face fresh U.S. restrictions on overseas access to advanced AI chips. Defensive sectors in the S&P 500 such as Consumer Staples (XLP) and Healthcare (XLV) both moved back near all-time highs before fading, but held up better than the rest of the S&P 500. Even tumbling oil prices and a slight easing in Treasury yields have not been able to stabilized the tech trade which has been in free fall for a few weeks now, even prior to the NVDA bombshell last week of CEO Jensen Huang stepping down amid reports of extra martial affairs, including one with a woman who was reportedly suspected of being a Chinese spy and another internal company individual.  Overall lots of investor concern heading into Nvidia earnings and Anthropic (ANT) IPO this week as the whole ai complex from semi chips, memory, data centers, opticals, infrastructure, cooling names ave been bleeding for weeks amid uncertainty. While the exodus in tech continues, names in Healthcare (XLV) and Consumer Staples (XLP) making new all-time highs today, among them including KO, LLY, MO and COST. Also this week, the Shenzhen APEC summit (Nov 16-20) is expected to bring a third Trump-Xi meeting of 2026, with the trade truce only temporarily extended. Lots of fear again as the CBOE Volatility index (VIX) jumped as much as 25% above the 24 level as stocks slipped.

 

Lots of weird instances going on the last few days that has a lot of people’s attention. Another tech outage messed with Wall Street and other individuals on Monday after several United States banks and financial institutions were hit, simultaneously, with widespread login issues. JP Morgan customers had reported that they cannot log in to online or mobile banking. Outage reports also surged for Bank of America, U.S. Bank, Wells Fargo, Truist, and Zelle, along with Microsoft 365, Outlook, and Teams. More issues now after the widespread Microsoft (MSFT) outage from late last week that lasted over two days impacting Outlook, Teams and other products, and then the FAA airline ground halt Friday and partial Saturday.

 

Technology stocks added to last Thursday/Friday sharp declines, under pressure ahead of Nvidia (NVDA) earnings Tuesday night and Anthropic’s (ANT) highly anticipated IPO later this week. Nvidia shares fall further amid leadership uncertainty after CEO Jensen Huang resigned last week following reports of affairs, including one with a woman who was reportedly suspected of being a Chinese spy and another internal company individual. There were also media reports this weekend that supporters of Jensen Huang are lobbying for his return to the AI chip giant following his abrupt resignation last week – however, CNBC reported this afternoon Nvidia’s board is not considering bringing Jensen Huang back as CEO. In addition to leadership uncertainty, elevated financing costs and competition for institutional AI allocations are the immediate catalysts for sector weakness. December Fed-rate-hike expectations are firmly established after last week’s inflation data. Among sectors tumbling with NVDA include broad semiconductor pressure linked to AI spending concerns (AMD, AVGO, MU, SNDK), Cloud-computing / financing sensitivity (CRWV, NBIS), AI data-center infrastructure weakness (IREN, HUT, APLD, WULF), Server makers sold with semiconductor complex (DELL, HPE, SMCI). Other concerns include this week’s Anthropic (ANT) IPO listing possibly drawing allocations away from existing AI positions.

Economic Data/Fed speakers

  • NY Fed's Empire State current business conditions index +7.8 in November (consensus 18.0) vs +25.5 in October; the new orders index +3.0 in November vs +23.2 in October; six-month business conditions index +28.9 in November vs +21.0 in October; NY Fed's Empire State employment index at +18.1 in November vs +10.3 in October; NY Fed's Empire State prices paid index +45.9 in November vs +59.5 in October.
  • Federal Reserve Bank of Cleveland President Beth Hammack reiterated that while she sees mounting inflation pressures she is not ready for the US central bank to shift to a more aggressive path of interest rate increases. “I like moving in smaller increments,” Hammack said in a Bloomberg TV interview. “I think the more predictable we can be, the better it is for businesses and households to be able to plan and to think about their finances,” she said.

Commodities

  • Another very broad sell off in the precious metals sector, with gold, silver, palladium and platinum all adding to pullbacks. December gold fell -$33.30 or 0.86% to settle at $3,853 an ounce while December silver prices dropped -$2.26 or 4.6% to end at $46.86 an ounce (a far cry off the $121 an ounce level back in January). Platinum and palladium also fall again, as both have lost more than 11% over the past month. The same pressures dragging gold and silver to one-year lows…a dollar at a 19-month high and bets on more Fed rate hikes. There's a demand worry, too. Platinum and palladium go mainly into catalytic converters for cars, and Monday's figures from China, the world's biggest auto market, showed factory output growing more slowly than expected in October and retail sales cooling.
  • Oil prices fell, giving some relief to recent inflation concerns, following signs of recovering oil flows through the Strait of Hormuz. The International Energy Agency said on Friday that the global oil market will return to a surplus in the fourth quarter of this year. U.S. WTI crude oil futures settle at $85.72 per barrel, down -$2.84, or 3.21% while Brent crude fell -$3.40 or 3.55% to settle at $92.44 per barrel. Prices for both are down about 6% from a week ago as traders lean into forecasts for a growing surplus. Stocks of crude oil in the US strategic Petroleum reserve fell to 276.4M barrels last week, lowest level since 1982.

Currencies & Treasuries

  • The U.S. dollar is the strongest versus the euro since April 2025, despite questions around the AI trade. (Since the end of September, the Nasdaq is down 6+% while the equal weight is up 6+%.) This raises questions of how connected US economic strength is tied to AI equity outperformance. The euro tests below 1.10 to the downside on rising interest rate hike expectations into FOMC meeting minutes due on Wednesday. Dollar index (DXY) tops 103.50 today.
  • US Treasury yields eased slightly on Monday after two-year yields on Friday registered their biggest weekly jump in two years, with a drop in equities giving bonds a slight safe-haven bid. Data last week showed consumer prices rose more quickly than expected in October, prompting markets to factor in more interest rate hikes in coming months. Recent hawkish Federal Reserve official commentary added to the rate hike views. Yields were sharply higher last week as traders saw rising chances that the US central bank could hike rates by a larger-than-usual 50 basis points in December, or raise rates by 25 basis points at each of the next three meetings.

 

Macro

Up/Down

Last

WTI Crude

-2.84

85.72

Brent

-3.40

92.44

Gold

-33.30

3,853.00

EUR/USD

-0.0013

1.1012

JPY/USD

-0.31

159.37

10-Year Note

-0.032

5.121%

 

Sector News Breakdown

Retail, Consumer Staples & Restaurants:

  • Off-price retailers: Truist previews Q3 earnings, saying they remain more bullish on ROST's differentiated approach/momentum. Ahead of Q3 results, Truist thinks key debates for off-price retailers are centered around 1) ROST's ability to sustain momentum into FY27 with increasingly difficult comparisons, 2) if/when Marmaxx can Re-accelerate comps, and 3) the Magnitude of potential weather headwinds (particularly at BURL). While Truist Card Data indicates trends have slowed over the past few weeks, Truist remains bullish on a strong Holiday season overall for off-price (particularly ROST ).
  • Food sector: TSN shares rebound after earnings results as Q4 adj EPS $0.61 top consensus of $0.60 on better revs $14.59B vs. consensus $14.1B though forecast a steeper-than-expected annual revenue decline; now sees FY27 revenue down 3.5% to 5.5% against analysts' 1% decline estimate and forecasts fiscal 2027 adjusted operating income of $1.7 billion to $2.15 billion. Defensive food stocks rallied CPB, GIS, CAG.
  • Specialty retailers: YETI was downgraded to Neutral from Buy at Goldman Sachs as softer U.S. DTC demand, slowing wholesale growth and rising input/freight costs reduce near-term growth and margin visibility.

Autos, Leisure, Gaming & Lodging:

  • Cruise line sector: VIK was double upgraded to Outperform from Underperform at Mizuho and raise PT to $120 from $82 noting shares have lagged materially, underperforming cruise peers (RCL and CCL) over the last 6 months, in large part due to lower River levels in Europe, which Mizuho believes to be transitory. There will be a material impact to '27 and '28; However, once that is digested, believes the focus shifts to '29, where it sees significant upside to numbers.
  • Casinos & Gaming sector: Nine Democratic senators including Adam Schiff (Calif.), Amy Klobuchar (Minn.) and Elissa Slotkin (Mich.) this morning sent a letter to the Commodity Futures Trading Commission (CFTC) asking it to freeze its efforts to assert its regulatory authority over prediction markets. The senators' request comes after the CFTC on Nov. 5 ordered prediction markets to cease geographic restrictions on their platforms within 30 days – WSJ reported.
  • Consumer Services: ARMK Q4 adjusted EPS $0.71 vs. est. $0.75 and revs $5.29B, in-line with consensus $5.29B; sees FY27 adjusted EPS growth 20%-25% vs. $2.23 in FY26; sees FY27 revenue growth 9%-10% vs. $20.09B in FY26; authorizes a $1B share buyback plan and raises dividend by 17%.
  • Auto sector: Chinese Ev maker XPEV Q3 revenue rose 19% y/y to Q3 revenue RMB 24.28B, consensus RMB 23.17B, driven by higher deliveries and improved product mix; its Q3 net loss widened y/y, while gross margin declined to 18.9%; forecasts Q4 deliveries to rise more than 40% y/y to between 169,000 and 174,000 after Q3 deliveries were 118,390; sees Q4 revenue between RMB30.40B and RMB31.80B.

Energy

  • Energy E&P sector: FANG said it would buy certain units of Texas-based energy producer Double Eagle in a $5.03B cash-and-stock deal. Under the deal, FANG will pay about $2.15B in cash and 15.56 million shares of Diamondback common stock. The assets include about 176,000 net acres in the core of the Midland Basin, with estimated 2027 oil production of about 35,000 barrels per day. In another deal, CNQ will acquire smaller peer Advantage Energy (AAVVF) in a deal valued at C$2.53B ($1.77B), including debt, as Advantage shareholders will receive C$13.55 in cash for each share held, implying a premium of nearly 25% its closing price on Friday. The deal includes production of roughly 79,000 barrels of oil equivalent per day from Montney and Charlie Lake assets, and a light crude oil and liquids-rich natural gas development inventory.

Financials

  • Crypto sector: Bitcoin comes into the week with a 6-week losing streak, and extending losses this morning as rising interest rate hike fears after hotter CPI inflation last week dented crypto appetite along with precious metals; Bitcoin falls below $65,000 (COIN, MSTR, IBIT, HOOD and Bitcoin miners all pressured).
  • Brokerage sector (HOOD, SCHW, ETOR, BULL, IBKR): Compass Point says they believe Anthropic (ANT) IPO can make or break 4Q Numbers. October trading activity increased slightly MoM alongside a favorable calendar shift. While October is historically eBrokers' best month of the year, choppy markets limited this year's sequential improvement. Industry commentary suggests November volumes are trending higher MoM. They view ANT's IPO as a barometer for whether retail brokers meet 4Q expectations.

Biotech & Pharma:

  • CGON shares jumped after positive phase 3 results for cretostimogene in bladder cancer; Phase 3 PIVOT-006 trial evaluated cretostimogene in non-muscle-invasive bladder cancer; treatment reduced the risk of recurrence by 68% versus current therapy in intermediate-risk patients.
  • CYTK said the FDA has approved a sNDA updating the U.S. Prescribing Information for MYQORZO(R) (aficamten) to include data from MAPLE-HCM, the Phase 3 trial comparing MYQORZO and the standard-of-care beta-blocker metoprolol, each as monotherapy, in adults with symptomatic oHCM.
  • INCY said it has decided not to proceed with the planned Phase 3 MAESTRA-3 study evaluating INCB123667, the company's selective CDK2 inhibitor, in combination with bevacizumab as first-line maintenance therapy in patients with ovarian cancer, which had been expected to begin in Q4.
  • JNJ is acquiring privately held Ollin Bio for $2.2 billion upfront. Ollin is developing treatments for diseases that caused age-related vision loss.
  • LLY will acquire privately held Calytrix, and Calytrix shareholders could receive up to $1.5B in cash.
  • LXEO shares jumped following positive interim trial results for a treatment for a rare genetic heart disease; said interim data from an ongoing Phase I/II clinical trial of LX2020, a treatment for PKP2 arrhythmogenic cardiomyopathy, strengthened its confidence in the drug's potential.
  • SMMT shares fall after saying the FDA declined approval of their lung cancer drug ivonescimab saying the drug's benefit in delaying disease progression does not support a favorable benefit-risk profile without a statistically significant improvement in overall survival. Ivonescimab plus chemotherapy cut the risk of disease progression or death by 48% vs. chemotherapy alone in a late-stage trial.
  • VKTX highlights clinical data from VK2735 obesity program at Obesity Week 2026; VK2735 treatment led to improvement in multiple cardiometabolic markers; said 74% of participants receiving VK2735 improved BMI category after 13 weeks.
  • ZYME announced that its Board of Directors has authorized a second 2026 share repurchase program under which the company may repurchase up to $200M of its outstanding common stock.

Healthcare Services & MedTech movers:

  • HSIC reduces FY2026 non-Gaap diluted eps guidance to $5.42-$5.48 from $5.50-$5.56 vs. consensus of $5.54 and sees FY sales growth outlook 4.5-5.5%; guidance is for current continuing operations and does not include impact of restructuring expenses.
  • MDT agreed to acquire Contego Medical for $380M, a private med device company focused on carotid artery disease and peripheral thrombectomy. Medtronic expects to complete the transaction in the third quarter of its fiscal year, subject to customary closing conditions.
  • MMED shares edged higher early after saying the FDA has cleared MiniMed Fit, the company's first tubeless insulin pump. Its launch is expected to begin with a phased rollout in the US in spring 2027, following an early customer experience phase. The pump is cleared for people with Type 1 and Type 2 diabetes ages 7 and older

Industrials & Materials

  • Transport sector: Friday's nationwide ground stop continued to impact airlines operations through the weekend. Using data from FlightAware, UBS calculated that the average cancelation rates across the top 6 US airlines was 32% on Nov 13, 30% on Nov 14, and ~10% on Nov 15 (as of 7pm ET). Delays % averaged 25 30% across each of the past 3 days. JBLU and AAL had the highest cancelation rates while LUV had the lowest cancelations % across the top 6. As of Sun evening, it appears that operations are set to improve meaningfully come Monday with cancel rates moderating to flat to LSD% across the major airlines. Friday's nationwide ground stop lasted for over 4 hours.
  • Defense sector: LHX shares fell after officials blamed a nationwide flight shutdown on the FAA contractor's router installation. Transportation Secretary Sean Duffy said Friday that LHX was conducting routine maintenance to switch telecommunication lines from old copper wire to fiber at least one remote location. Duffy said investigators had not determined whether installer error or faulty equipment caused the disruption, which affected communications at 17 of 22 FAA en route centers. Drone maker USAR shares fell after William Blair downgraded to MP from OP saying recent feedstock shortages add to its list of near-term challenges/ pushing out USA Rare Earth's sales and margin estimates well into 2028.
  • Aerospace sector: A Vulcan rocket owned by United Launch Alliance, the joint venture of BA and LMT, failed on Sunday shortly after liftoff from Florida, destroying its payload of 40 satellites from Amazon's Leo internet network in the launch company's first mission failure. The rocket failed roughly 10 minutes after liftoff from the Cape Canaveral Space Force Station in Florida, and the cause was not immediately clear. YSS was upgraded from Hold to Buy at Canaccord after earnings results and PT lowered from $13.50 to $9 noting Q3 revenue of $84.2M declined 7.3% Y/Y, and adjusted EBITDA loss was $27.6M; results missed Canaccord's estimates by approximately 18% and 105%.

Materials, Metals & Mining

  • Chemical sector: Keybanc said they are is reassessing their contrarian position on Crop chemicals and taking a step back, reducing its estimates, and becoming more Selective with its picks. The firm downgraded FMC to Sector Weight as the risk from a prolonged downturn can materially affect its turnaround plan while believes that CTVA is better positioned to weather a delayed recovery. The firm notes underlying demand and pricing for Crop chemicals appear weaker than expected, especially in South America.
  • Paper & Forest sector: CLW announced new leadership appointments; announces Q3 price increase: $50/ton cup, $60/ton folding carton; reaffirms Q4 2026 guidance of $10M-$20M adj ebitda; says Cypress Bend mill outage completed; mill resuming normal operations; expects 2027 capital expenditures within $70 mln-$80 mln maintenance plus $10 mln-$20 mln for projects. Truist noted in the boxboard sector (GPK, SW, GEF), according to Fastmarkets RISI's (RISI) Paper Packaging Monitor, SBS operating rates and pricing could decline over the next few years, barring any future additional capacity closures.
  • Metals & Mining sector: NUE was upgraded to Buy from Neutral at UBS and raise tgt to $307 from $256 saying despite higher hot-rolled coil prices since June, Nucor shares are broadly flat. The firm sees upside to 2027 EBITDA estimates for the company amid expanding backlogs.

Technology

  • NVDA shares stay weak as investors digested a report that supporters of Jensen Huang are lobbying for his return to the AI chip giant following his abrupt resignation last week. Huang has discussed returning as CEO with confidants, the Financial Times reported Sunday. Huang resigned last week following reports of affairs, including one with a woman who was reportedly suspected of being a Chinese spy.
  • New Commerce Department rules impose additional licensing requirements affecting advanced-processor transfers to data centers in several countries. The same market roundup reported that Baidu’s AI businesses helped offset weakness in online advertising.
  • AI sector focused on Anthropic (ANT) IPO this week. Anthropic is expected to price its initial public offering (IPO) on Wednesday, Nov. 18. It will begin trading on Thursday, Nov. 19. In an amended S-1 filing, Anthropic said it expects to sell 825 million shares priced between $70 and $78. That would give the company a market valuation of between $1.3 trillion and $1.45 trillion. Anthropic was initially projected to hit the market with a valuation as high as $2 trillion, but recent market turmoil in the AI sector has knocked that down significantly.
  • AI Infrastructure sector: Server makers' shares continue to slide with shares of DELL, SMCI, HPE lower again, adding to last week’s losses following a leadership crisis at AI chip giant NVDA has exacerbated AI worries amid concerns over spending. DELL has dropped over 40% from Sept peak, HPE down ~34% from Oct record high, SMCI has slumped 75%+ from March 2024 peak.
  • HPC Data Center stocks remain weak with more notable declines for IREN, HUT, CIFR, WULF, CLSK and others. IREN is now -57% YTD and -32% on the month adding to weakness in the data center/HPC compute sector after the Midterm elections added to already negative sentiment in the space on moratorium build concerns - especially in Texas. Other names extending declines include CIFR -56% YTD and -12.5% MTD, and CLSK (-39% YTD and -19% this month)
  • Data Centers: Blackstone Digital Infrastructure Trust (BXDC) said it agreed to acquire a 75.1% controlling interest in a $5B joint venture with Amazon Data Services (AMZN), comprising 13 newly built data centers in Indiana and Mississippi with 647 MW of capacity. The transaction values the properties at a 7.0% initial cap rate and will be funded with $1.9B of Blackstone equity and approximately $2.5B of non-recourse mortgage debt, with Amazon retaining a 24.9% stake. Amazon will lease 100% of the properties under 12-year initial triple-net leases, with 2.75% annual rent escalators and parent guarantees.

Not offered or endorsed by Regal Securities

Street Recommendations

Tuesday, November 17, 2026

BARCLAYS

  • BLCO Barclays analyst Christopher Pasquale raised the firm's price target on Bausch + Lomb to $27 from $24 and keeps an Overweight rating on the shares. The firm says Bausch is executing well against the plan it laid out at its 2025 investor day. It continues to view the stock's risk/reward as positively skewed.
  • EXPD Barclays raised the firm's price target on Expeditors to $200 from $175 and keeps an Underweight rating on the shares. The company's investor day will likely highlight solid ocean demand supported by lower U.S. tariffs and surging air freight driven by AI data centers, the analyst tells investors in a research note. However, the firm believes the market will question if Expeditors' earnings are near peak.
  • RDNT Barclays raised the firm's price target on RadNet to $83 from $79 and keeps an Overweight rating on the shares. The company needs to sustain its elevated rate of core EBITDA growth to meet Q4 expectations, the analyst tells investors in a research note. However, Barclays remains constructive on RadNet's path to do so and sees upside to 2027 consensus estimates.

BERNSTEIN

  • PEP Bernstein analyst Cristian Rios downgraded PepsiCo to Underperform from Market Perform with a price target of $128, down from $131. The firm expects PepsiCo to miss earnings expectations over the next 12 months. This will be driven by underperformance in North America, the analyst tells investors in a research note. Bernstein says the shares will see multiple compression as the market "prices the new reality of an algorithm that requires significant catch-up investment to be sustained."
  • TSN Bernstein raised the firm's price target on Tyson Foods to $72 from $66 and keeps a Market Perform rating on the shares. While guidance for FY27 is below consensus expectations at the midpoint, there seems to be more evidence that the beef cattle herd is starting to rebuild, the firm says.
  • XPEV Bernstein analyst Eunice Lee lowered the firm's price target on XPeng to $15 from $18 and keeps a Market Perform rating on the shares. The firm notes XPeng's Q3 losses narrowed sequentially primarily on stronger vehicle mix. The company provided strong Q4 delivery guidance, but weaker mix and higher R&D keep XPeng in loss territory, adds Bernstein.

BOFA

  • KKR BofA lowered the firm's price target on KKR to $137 from $138 and keeps a Buy rating on the shares. Following results, the firm increased its Q4 and 2027 distributable earnings estimates, but reduced its 2028 estimate to $8.79 from $8.93 driven by modestly lower fundraising in 2027-28.

CITI

  • ORIC Citi raised the firm's price target on Oric Pharmaceuticals to $17 from $16 and keeps a Buy rating on the shares. The firm says the company's Q3 report "builds further conviction" that rinzimetostat plus darolutamide can deliver prostate cancer efficacy that is competitive with mevrometostat plus enzalutamide. It cites an increased probability of success for enozertinib for the target boost.
  • GXO Citi analyst Ariel Rosa raised the firm's price target on GXO Logistics to $71 from $66 and keeps a Buy rating on the shares following the investor day. The company's 7% annual revenue growth target through 2030 is above expectations, the analyst tells investors in a research note.
  • TMUS Citi raised the firm's price target on T-Mobile to $185 from $165 and keeps a Neutral rating on the shares. The firm cites the stock's recent outperformance for the target boost. It believes investor sentiment on the telecom sector has become more balanced over the last couple of weeks amid a "stabilizing competitive dynamic" in wireless.
  • ZM Citi analyst Tyler Radke raised the firm's price target on Zoom Communications to $131 from $126 and keeps a Buy rating on the shares. The firm expects the company to report a Q3 beat. Partner checks and Zoom's recent analyst day bring confidence in a "modest" growth acceleration through the second half of the year, the analyst tells investors in a research note.
  • BMBL Citi raised the firm's price target on Bumble to $6.05 from $3.20 and keeps a Neutral rating on the shares. The firm cites the company's acquisition agreement by Ithaca Holdings for the target boost. It sees the transaction as an "attractive outcome" for Bumble shareholders.

DEUTSCHE BANK

  • AMT Deutsche Bank initiated coverage of American Tower with a Buy rating and $222 price target.
  • CCI Deutsche Bank initiated coverage of Crown Castle with a Hold rating and $96 price target.
  • SBAC Deutsche Bank initiated coverage of SBA Communications with a Hold rating and $211 price target.

EVERCORE ISI

  • FOUR Evercore ISI lowered the firm's price target on Shift4 Payments (FOUR) to $40 from $45 and keeps an In Line rating on the shares. Shift4 and Robinhood (HOOD) are "navigating challenging waters," says the analyst, whose target prices for both companies have been adjusted downward, reflecting lower earnings expectations and a tougher outlook through 2027.
  • HOOD Evercore ISI analyst Adam Frisch lowered the firm's price target on Robinhood (HOOD) to $100 from $130 and keeps an Outperform rating on the shares. Shift4 (FOUR) and Robinhood are "navigating challenging waters," says the analyst, whose target prices for both companies have been adjusted downward, reflecting lower earnings expectations and a tougher outlook through 2027.

GOLDMAN SACHS

  • TSN Goldman Sachs analyst Leah Jordan raised the firm's price target on Tyson Foods to $70 from $62 and keeps a Buy rating on the shares. Goldman continues to have confidence in Tyson's diversified protein model, as improving trends in beef should more than offset a softer industry backdrop for chicken in the year ahead, while the firm is also encouraged by ongoing operational improvements and continued demand strength across its segments, especially for its value-added portfolio, the analyst tells investors in a research note.

GUGGENHEIM

  • VCYT Guggenheim lowered the firm's price target on Veracyte to $35 from $65 and keeps a Buy rating on the shares. The firm updated its model to reflect Q3 reported results and management's commentary on the call.
  • RARE Guggenheim lowered the firm's price target on Ultragenyx to $24 from $35 and keeps a Buy rating on the shares, citing the discontinuation of the Angelman and Wilson's disease programs for the firm's lowered target.

HSBC

  • CSCO HSBC upgraded Cisco to Buy from Hold with a price target of $133, up from $120. The company reported strong fiscal Q1 results and raised its fiscal 2027 earnings guidance, the analyst tells investors in a research note. HSBC cites Cisco's valuation and business momentum for the upgrade. It sees solid growth, low capex, and an attractive valuation.

JEFFERIES

  • IDA Jefferies analyst Julien Dumoulin-Smith downgraded Idacorp to Hold from Buy with a price target of $163, up from $155. The firm cites valuation for the downgrade. Idacorp shares are trading at a double-digit premium to peers as its near-term positive catalysts are largely known, the analyst tells investors in a research note. Jefferies believes Idacorp is "clearly differentiated" and deserves a premium valuation. However, the company's fundamentals are now adequately reflected in the shares, contends the firm.

JPMORGAN

  • TSN JPMorgan downgraded Tyson Foods to Neutral from Overweight with a price target of $65, up from $63. The shares were up 9% yesterday following the fiscal Q4 report and up 23% over the past two months, the analyst tells investors in a research note. JPMorgan is "encouraged" by Tyson's recovery in beef and stabilization in chicken but also believes the stock price recovery better reflects the company's underlying fundamentals. It cites valuation for the downgrade.
  • MRNA JPMorgan analyst Jessica Fye raised the firm's price target on Moderna to $102 from $77 and keeps an Underweight rating on the shares. The firm cites the company's analyst day and updated 2026 guidance for the target boost. JPMorgan sees the interim for intismeran's randomized Phase II trial in adjuvant renal cell carcinoma as the next key event for the stock, potentially in late 2026.
  • NXT JPMorgan lowered the firm's price target on Nextpower to $133 from $134 and keeps an Overweight rating on the shares. The company's second capital markets day "marked a meaningful acceleration of the multi-year strategy outlined just a year ago," the analyst tells investors in a research note. The firm says Nextpower's fiscal 2030 revenue and earnings targets were increased well above expectations. JPMorgan continues to view Nextpower as "best-in-class" within its renewables coverage.

KEEFE BRUYETTE

  • SCM Keefe Bruyette lowered the firm's price target on Stellus Capital to $7.50 from $8 and keeps a Market Perform rating on the shares. Stellus Capital had a weak quarter with NAV down 3.1% and rising non-accruals, while elevated leverage limits further buybacks and near-term deleveraging prospects, the analyst tells investors in a research note.
  • SLRC Keefe Bruyette analyst Paul Johnson lowered the firm's price target on SLR Investment to $13 from $13.50 and keeps a Market Perform rating on the shares post the Q3 report. The company's earnings were slightly better than expected but its net asset value declined due to write-downs on non-accrual investments, the analyst tells investors in a research note.

LOOP CAPITAL

  • PRG Loop Capital downgraded Prog Holdings to Hold from Buy with an unchanged price target of $40.

MORGAN STANLEY

  • PWR Morgan Stanley initiated coverage of Quanta Services with an Equal Weight rating and $636 price target. The company's scale and power exposure are attractive, but the stock's valuation already reflects "substantial growth," the analyst tells investors in a research note.
  • MTZ Morgan Stanley analyst Stefan Diaz initiated coverage of MasTec with an Equal Weight rating and $220 price target. The company offers "multiple earnings drivers," but uncertainty about communications demand and execution make it a "show me" story, the analyst tells investors in a research note.
  • NUE Morgan Stanley analyst Carlos De Alba upgraded Nucor to Overweight from Equal Weight with a price target of $310, up from $300. The firm upped its near-term steel price forecasts citing sustained tight supply. With an "unfavorable sector risk-reward," Morgan Stanley favors "defensive quality" in the North America steel group. It cites Nucor's declining capex and volume growth from recent investments for the upgrade.
  • STLD Morgan Stanley raised the firm's price target on Steel Dynamics to $270 from $260 and keeps an Equal Weight rating on the shares. The firm upped its near-term steel price forecasts citing sustained tight supply. With an "unfavorable sector risk-reward," Morgan Stanley favors "defensive quality" in the North America steel group.
  • FIX Morgan Stanley initiated coverage of Comfort Systems USA with an Overweight rating and $1,410 price target. The stock's recent de-rating has created an attractive entry point, the analyst tells investors in a research note. The company's record backlogs suggests upside to 2027 estimates, the analyst tells investors in a research note. Morgan Stanley says Comfort Systems offers "differentiated modular capabilities, capacity expansion and potential margin upside."
  • EME Morgan Stanley initiated coverage of Emcor with an Overweight rating and $799 price target. The stock's recent de-rating has created an attractive entry point, the analyst tells investors in a research note. The company's record backlogs suggests upside to 2027 estimates, the analyst tells investors in a research note. Morgan Stanley says Emcor "combines consistent execution, diversified end-market exposure, with an acquisition strategy that adds skilled labor at attractive valuations."
  • MRNA Morgan Stanley raised the firm's price target on Moderna to $200 from $95 and keeps an Equal Weight rating on the shares. The firm, which updated its model following the presentation of Phase 3 adjuvant melanoma data at ESMO and the company's analyst day on November 13, raised its intismeran estimates.
  • GXO Morgan Stanley raised the firm's price target on GXO Logistics to $85 from $78 and keeps an Overweight rating on the shares following GXO's "much awaited Investor Day." The event "held several surprises - from strategies to targets - which in our view showed that the virtually 'all-new' mgmt. team has several aces up their sleeve," the analyst tells investors.
  • EMR Morgan Stanley raised the firm's price target on Emerson to $175 from $140 and keeps an Underweight rating on the shares. Based on historical backlog coverage, the current $9.6B backlog would signal $20.2B FY27 revenue, the analyst tells investors.

PIPER SANDLER

  • MDT Piper Sandler analyst Matt O'Brien upgraded Medtronic to Overweight from Neutral with a price target of $120, up from $85. The company's "multiple growth drivers" should result in sales results ahead of the Street in the coming years, the analyst tells investors in a research note. Piper believes this will push the shares higher in the coming months. Piper says Medtronic's growth catalysts will become more clear at the company's investor meeting on December 11.
  • TSN Piper Sandler raised the firm's price target on Tyson Foods to $72 from $56 and keeps an Overweight rating on the shares. The firm is cautiously optimistic that Beef profitability is trending in the right direction, with the upper end of Tyson's Beef EBIT margin now suggesting a profitable year is possible, helped by its restructuring initiatives. Higher chicken feed costs will weigh on Chicken's margins in 2027, though consumer demand for chicken remains strong, adds Piper.
  • CNTB Piper Sandler analyst Biren Amin lowered the firm's price target on Connect Biopharma to $5 from $7 and keeps an Overweight rating on the shares after the company reported Q3 results and provided a business update. The next anticipated milestones are FDA discussions on a potential Phase 3 program for acute asthma exacerbations in December 2026 and for COPD in Q1 2027. For asthma, a key design question is whether FDA will align on the proposed baseline FEV1 cutoff of less than 80% predicted, the subgroup which rademikibart reduced treatment failure by 86% vs placebo in the Phase 2 Seabreeze study, the firm says. Piper moved the potential launch timing of rademikibart to 2030 from 2029.
  • JSPR Piper Sandler analyst Biren Amin lowered the firm's price target on Jasper Therapeutics to $44 from $60 and keeps an Overweight rating on the shares after the company reported Q3 earnings and reiterated its catalyst calendar. With Stage 1 of the Phase 2 renal basket study evaluating vensobafusp alfa now fully enrolled with 18 IgAN pts, the interim efficacy readout continues to be guided to year-end 2026, with an additional update in Q2 2027, the firm notes. Additionally, expansion cohorts began to enroll C3G/IC-MPGN patients and will begin to enroll FSGS patients in Q1 2027.

RBC CAPITAL

  • CYH RBC Capital analyst Ben Hendrix lowered the firm's price target on Community Health to $3 from $4 and keeps an Outperform rating on the shares. The company reported Q3 results below expectations as elective procedure volumes and payor mix fell short of internal expectations, prompting management to lower its full-year guidance, the analyst tells investors in a research note. RBC adds however that it remains focused on the strong top-of-funnel data and the potential for clinical visit growth to translate to high-margin elective volume in the near-term.

TD COWEN

  • KO TD Cowen analyst Robert Moskow raised the firm's price target on Coca-Cola to $112 from $104 and keeps a Buy rating on the shares. The analyst also named Coca-Cola a best idea for 2027. The company's international footprint and "advantaged" franchise bottling system position it to grow organic sales at 5%, well above peers, the analyst tells investors in a research note. TD says that despite the rally this year, the stock will move higher as Coca-Cola proves it can overcome rising inflation and tough comparisons.

WEDBUSH

  • ACRS Wedbush downgraded Aclaris Therapeutics to Neutral from Outperform with a price target of $3, down from $8, after the Phase 2 ADMIRATION trial of bosakitug for atopic dermatitis failed to meet primary or secondary efficacy endpoints. Aclaris has reprioritized ATI-052 for eosinophilic esophagitis and although ATI-052 could be the first combination therapy to enter clinical development, the firm has grown concerned Aclaris "may not maintain a timeline lead in EoE," the analyst tells investors.
  • LRMR Wedbush lowered the firm's price target on Larimar Therapeutics to $9 from $11 and keeps an Outperform rating on the shares. With the nomlabofusp BLA submission completed last week, the Q3 financial results release was a non-event for Larimar, the firm says. Most important in the near term is the BLA acceptance coming potentially in January, and PDUFA assignment.
  • BNTC Wedbush raised the firm's price target on Benitec Biopharma to $20 from $17 and keeps an Outperform rating on the shares. The firm says Q1 update provided no material new information after Benitec achieved two major milestones in the quarter, namely FDA feedback on the pivotal Phase 3 plan, which Wedbush believes should support an open-label study, and the clinical update from the Phase 1b/2a study at ESGCT, which demonstrated strong consistency and durability of BB-301's efficacy by continuing to show a 100% responder rate. The firm thinks that the favorable FDA feedback is likely due to the agency's recognition of the encouraging clinical benefit that BB-301 brings to dysphagic patients with oculopharyngeal muscular dystrophy, and that the clinical and regulatory progress should support a higher probability of success for the program.
  • RZLT Wedbush raised the firm's price target on Rezolute to $10 from $6 and keeps an Outperform rating on the shares after last Friday's announcement of positive preliminary data from the Phase 3 upLIFT study of ersodetug in tumor hyperinsulinism and its follow-up discussion with management about the plan for BLA submissions for both congenital HI and tumor HI. The price target increase was based on a higher probability of success for both congenital HI and tumor HI in the U.S., higher market penetration in U.S. tumor HI patients, and adding back to its valuation the ex-U.S. revenues for congenital HI.

WELLS FARGO

  • ZBH Wells Fargo upgraded Zimmer Biomet to Overweight from Equal Weight with a price target of $123, up from $113. The firm says Monogram should lift Zimmer's knee and worldwide growth. Monogram is the company's CT-based autonomous robot initially targeting total knee procedures, the analyst tells investors in a research note. Wells expects Monogram to succeed and "ramp quickly," saying it will be the first autonomous orthopedic robot from a major player. Monogram addresses the "one weak spot" in Zimmer's portfolio as the rest of it is growing mid-single digits, adds the firm.
  • PRAX Wells Fargo analyst Benjamin Burnett upgraded Praxis Precision to Overweight from Equal Weight with a price target of $509, up from $343. Following the investor day, the firm is more positive on the robustness of ulixacaltamide's D56 result, says the analyst, who cites higher odds of success for ulixacaltamide and relutrigine for the firm upgrade.
  • CAH Wells Fargo raised the firm's price target on Cardinal Health to $321 from $277 and keeps an Overweight rating on the shares. The firm cites strong Q1 2027 results and FY27 guidance raise. FY27 still appears set up well, with potential upside in organic Pharma growth and contributions from capital deployment, Wells adds.
  • GXO Wells Fargo analyst Christian Wetherbee raised the firm's price target on GXO Logistics to $75 from $65 and keeps an Overweight rating on the shares. The firm says GXO delivered what investors wanted, keeping 2027 intact, while adding credibility to the 2030 path. Growth looks big but increasingly supported, with margin levers largely in its control. With acceleration coming post-2027, execution will be key, Wells adds.
  • INTU Wells Fargo raised the firm's price target on Intuit to $330 from $300 and keeps an Equal Weight rating on the shares. One quarter into Intuit's reset, Q1 is unlikely to change sentiment with no read on tax until Q3 and the full year guide typically held, the firm says.
  • CHD Wells Fargo raised the firm's price target on Church & Dwight to $125 from $115 and keeps an Overweight rating on the shares. The firm says the company taking a 45% stake in a European-based hair care asset has two major outcomes in its view, namely a statement of intent on the hair care category, with a notable expansion to hair washing/treatment; and Church & Dwight following through on its stated International M&A plans.

Rating abbreviations…

***OP = Outperform

***SP = Sector Perform

***UP = Underperform

***OW = Overweight

***EW = Equal-weight

***UW = Underweight

 

 

 

 

 

***Report powered by thefly.com***

What’s on Tap Weekly Calendar

 

Monday November 16th

Economic Calendar: 

  • 8:30 AM ET NY Empire Manufacturing for November

Earnings Calendar:

  • Earnings Before the Open: ARMK BEKE BIDU BLDP BXDC DTST GAME HTHT IQ PERI POET TSN VENU XPEV XTNT XXII
  • Earnings After the Close: ACM AYTU BAER BRFH DARE DUOT FTLF INFQ MNTK OMER PAGS PARA POWL RCAT SHAZ STEM TMS TRAK WRAP XP YALA

Other Key Events:

  • Piper Sandler Financial Services Conference, 11/16-11/18, in Miami, FL
  • RBC Capital Markets Global Industrials Conference 11/16-11/17, in New York
  • Roth Capital 13th Annual Solar & Storage Symposium at RE +, 11/16-11/18, Las Vegas
  • Supercomputing 2026, 11/15-11/20, in New Orleans

Tuesday November 17th

Economic Calendar: 

  • 7:45 AM ET ICSC Weekly Retail Sales
  • 8:30 AM ET                   Retail Sales M/M for October
  • 8:30 AM ET                   Retail Sales – Less Autos M/M for October
  • 8:30 AM ET                   Import Prices M/M for October
  • 8:30 AM ET                   Export Prices M/M for October
  • 8:55 AM ET                   Johnson/Redbook Weekly Sales
  • 9:15 AM ET                   Industrial Production M/M for October
  • 9:15 AM ET                   Capacity utilization for October
  • 10:00 AM ET                 Business Inventory M/M for September
  • 10:00 AM ET NAHB Housing Market Index for November
  • 4:30 PM ET API Weekly Inventory Data

Earnings Calendar:

  • Earnings Before the Open: AS DIS ENR ESLT FUBO GFF HD HUYA JD KLAR LUXE MNSO ONEW OPRA SMWB SR TME VIK WB
  • Earnings After the Close: DLB GBDC GLAD IIIV IRIX LZB NVDA SQM WAST ZTO

Other Key Events:

  • Citizens Financial Services Conference, 11/17, in New York
  • Deutsche Bank Residential REIT summit (virtual), 11/17
  • Deutsche Bank 5th Annual Global Space Summit, 11/17-11/18, in New York
  • Jefferies 5th Miami Consumer Conference, 11/17-11/18, in Miami, FL
  • Piper Sandler Financial Services Conference, 11/16-11/18, in Miami, FL
  • RBC Capital Markets Global Industrials Conference 11/16-11/17, in New York
  • RBC Capital 2026 Global TIMT Conference, 11/17-11/18, in New York
  • Rosenblatt Silicon Valley field trip, 11/17-11/18
  • Roth Capital 13th Annual Solar & Storage Symposium at RE +, 11/16-11/18, Las Vegas
  • Roth Capital 15th Annual Technology Conference, 11/17-11/18, in New York
  • Supercomputing 2026, 11/15-11/20, in New Orleans
  • TD Cowen 2026 Financials & Fintech Conference, 11/17-11/18, in New York

Wednesday November 18th

Economic Calendar: 

  • 7:00 AM ET MBA Mortgage Applications Data
  • 8:30 AM ET                   Housing Starts M/M for October
  • 8:30 AM ET                   Building Permits M/M for October
  • 10:00 AM ET                 Pending Home Sales M/M for October
  • 10:30 AM ET                 Weekly EIA Inventory Data
  • 1:00 PM ET US Treasury to sell $13B in 20-year notes
  • 4:00 PM ET                    Net Long-term TIC Flows for September

Earnings Calendar:

  • Earnings Before the Open: BLSH BRBR CSHR GLBE GLNG JJSF JMIA KRNT LOW PONY PRE TCEHY TGT TJX ZIM ZKH
  • Earnings After the Close: CPA HP JOYY KLIC NJR P PANW PCYO RRGB SBLK UGI UTI WWD

Other Key Events:

  • Deutsche Bank 5th Annual Global Space Summit, 11/17-11/18, in New York
  • Jefferies 5th Miami Consumer Conference, 11/17-11/18, in Miami, FL
  • Piper Sandler Financial Services Conference, 11/16-11/18, in Miami, FL
  • RBC Capital 2026 Global TIMT Conference, 11/17-11/18, in New York
  • Rosenblatt Silicon Valley field trip, 11/17-11/18
  • Roth Capital 13th Annual Solar & Storage Symposium at RE +, 11/16-11/18, Las Vegas
  • Roth Capital 15th Annual Technology Conference, 11/17-11/18, in New York
  • Supercomputing 2026, 11/15-11/20, in New Orleans
  • TD Cowen 2026 Financials & Fintech Conference, 11/17-11/18, in New York

Thursday November 19th

Economic Calendar: 

  • 8:30 AM ET                   Weekly Jobless Claims
  • 8:30 AM ET                   Continuing Claims
  • 8:30 AM ET                   Philly Fed Business Index for November
  • 10:00 AM ET                 Leading Index M/M for October
  • 10:30 AM ET                 Weekly EIA Natural Gas Inventory Data
  • 11:00 AM ET                 Kansas City Fed Manufacturing for November

Earnings Calendar:

  • Earnings Before the Open: ARBE BABA BBWI DAO EVGN FUTU LQDT MANU MMS NTES RERE ROAD TEN VVV WMG WMT YMM
  • Earnings After the Close: BULL CLIR EARN ESE ESTC GAP GLOB INTU KEYS MATW NGVC POST ROST

Other Key Events:

  • Deutsche Bank Gaming, Lodging, Leisure One on One Conference 11/19-11/20, in Miami, FL
  • Supercomputing 2026, 11/15-11/20, in New Orleans

Friday November 20th

Economic Calendar: 

  • 10:00 AM ET                 University of Michigan Confidence, Nov-Final
  • 10:00 AM ET                 University of Michigan 1-yr and 5-yr inflation expectation, Nov -Final
  • 1:00 PM ET                    Baker Hughes Weekly rig count data

Earnings Calendar:

  • Earnings Before the Open: BJ BKE BSP FRO RLX WRD

Other Key Events:

  • Deutsche Bank Gaming, Lodging, Leisure One on One Conference 11/19-11/20, in Miami, FL
  • Supercomputing 2026, 11/15-11/20, in New Orleans

 

 

.

As a value-added service exclusive to Regal Securities account holders, The Hammerstone Report is available to read daily on the trading platform.

Hammerstone Inc. (the “Report”) provides information and data and does NOT provide any individual investment advice or money management assistance and does NOT attempt to influence the sale or purchase of securities. The Report is intended for informational purposes only and does not claim to be actionable for investment decisions. The information contained in the Report has been obtained from sources deemed to be reliable but is not represented to be complete, and it should not be relied upon as such. The Report does not purport to be a complete analysis of any security, issuer, or industry and is not an offer or a solicitation of an offer to buy or sell any securities. The Report is prepared for general information purposes only and does not consider the specific investment objectives, financial situation, and particular needs of any individual subscriber, person, or entity.

Content is provided for educational and informational purposes only and Regal Securities cannot attest to its accuracy or completeness. No information provided has been endorsed by Regal Securities and does not constitute a recommendation by Regal Securities to buy or sell a particular investment. You are solely responsible for your own investment decisions and Regal Securities makes no investment recommendations and does not provide financial, tax, or legal advice. Regal Securities may provide links to internet sites maintained by third parties. Unless expressly stated otherwise, links in these reports are not sponsored by nor are they the responsibility of Regal Securities. Regal Securities has not verified the content, accuracy, or opinions expressed on any links in these reports and disclaims any warranty or liability for damages associated therewith.

Copyright 2006-2026 Regal Securities, Inc., Member FINRA/SIPC | Important Disclosures

Your privacy is important to us; see our Privacy Policy for details.

Regal Securities, 950 Milwaukee Ave., Ste. 102, Glenview, IL 60025
Website: www.regalsecurities.com | Toll-free: 1-877-488-6534
Representatives are available Monday through Friday from 8:00 a.m. to 5:00 p.m. EST.